Vulvovaginal candidiasis (VVC) is the second most frequent vaginal infection in women and occurs as an opportunistic infection generally caused by Candida albicans.The objective of the research is to determine the risk factors for developing VVC in women of reproductive age, pregnancy, and postmenopausal age. A 6-month prospective study was carried out in pregnant women, post-menopausal women, and women of reproductive age. In MS Excel 2007, the obtained cases were entered, and descriptive statistics were utilized to calculate the percentage of various parameters.The research consisted of a total of 90 individuals, whose participants ranged in age from 18 to 65. VVC was more common (40%) among females there in the reproductive ages of 18 to 35 (86.7%) of the 90 patients who don't follow regular exercise and 54.4 % have a BMI range (of 25-29.9) Overweight. Obesity, past medical and medication history such as Diabetes mellitus (27.7%), and antibiotic usage (23.3%) were major risk factors for acquiring VVC. Co-morbidities like diabetic mellitus, hypothyroidism, urinary tract infections, obesity, as well as PCOD are the main risk factors to cause VVC. Antibiotic usage in the past, the consumption of steroids, and an absence of regular exercise all contribute to the emergence of VVC.

Dysfunctional uterine bleeding (DUB) is defined as bleeding from the uterine corpus that is abnormal in regularity, volume, frequency, or duration and occurs in the absence of pregnancy. Methylprogesterone (MPA) and Norethisterone (NE) are a sort of female hormone (progestin).To cure dysfunctional uterine bleeding, this study sought to determine how MPA and NE worked. Materials and Procedures Over three months, a prospective observational study was conducted at a hospital in Palakkad. The usefulness of MPA and NE is analyzed by using the PBAC score method. Using Microsoft Excel 2007, the cases were entered, and descriptive statistical analysis was then performed. Results and Discussion There were 71 respondents in this study, with ages ranging from 18 to 35 and older. 32 of the 71 people received MPA, whereas 39 of them acquired NE. DUB was much more prevalent in women over 35 (NE-56.4% and MPA-75%). DUB is usually seen in overweight individuals (NE: 56.4%; MPA: 50.). The PBAC score dropped after both medications were administered. Norethisterone is more effective than either of the drugs, as per this study.